This episode skillfully breaks down the extensive complexity of research methodologies, covering everything from initial query to overall implications
The following search string was used: #1"Parkinson Disease"[mh] OR Parkinson* [tw]) AND #2"Glucagon-Like Peptide 1"[mh] OR"GLP-1 receptor agonists"[tw] OR"glucagon-like peptide-1"[tw] OR GLP-1 [tw] OR liraglutide [tw] OR exenatide [tw] OR dulaglutide [tw] OR semaglutide [tw] OR lixisenatide [tw]) AND #3"Metabolism"[mh] OR metabolism [tw] OR"Body Weight"[mh] OR"body weight"[tw] OR"Obesity"[mh] OR obesity [tw] OR"Diabetes Mellitus"[mh] OR diabetes [tw] OR neuroprotection [tw]) AND English [la] AND ("2000"[dp]:"2025"[dp]) Study Selection The following authors, IAO and CEV, independently reviewed the titles and abstracts of all identified articles
What the single vs dual vs triple difference actually means The main axis of comparison is not "better/worse" but the number of signaling pathways engaged
Do not use the same site for each injection What are the possible side effects of Saxenda
Obesity is a complex chronic disease that requires multimodal and usually lifelong treatment, i.e
However, at 80% new GLP-1 patients, this has clearly reduced the fears around cannibalisation
